Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
you are here: HomeNewsOpinion

Growth drivers are finally falling in place for large pharma companies

Analysts project a notable improvement in revenue growth rates at Sun Pharma, Dr Reddy’s Labs, Cipla vis-à-vis FY17-22

November 09, 2022 / 09:22 AM IST
Growth drivers are finally falling in place for large pharma companies

Highlights Sun Pharma, Dr Reddy’s Labs and Cipla see upgrades in earnings estimates after September quarter results All three companies have clocked healthy growth in US sales last quarter The companies’ efforts to mitigate the impact of US generic price erosion are beginning to bear fruit Large pharmaceutical companies that sell finished dosage drugs in India and abroad are finally getting a grip on growth. After years of unexciting results Sun Pharmaceutical Industries, Dr Reddy’s Laboratories and Cipla have seen upgrades in earnings...

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers